Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course

scientific article published on 10 January 2018

Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41398-017-0064-8
P932PMC publication ID5802532
P698PubMed publication ID29317609

P50authorDiana KuhQ32985047
Mark James RawleQ58571556
Marcus RichardsQ64539350
Andrew WongQ37390075
Rebecca BendayanQ49962422
Daniel DavisQ49962435
P2860cites workApolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid ProteinQ22250908
ApoE promotes the proteolytic degradation of AbetaQ24651102
Cognitive change and the APOE epsilon 4 alleleQ28219219
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseQ28238269
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumQ28252389
Cohort Profile: The 1946 National Birth Cohort (MRC National Survey of Health and Development)Q28275493
Apolipoprotein E: cholesterol transport protein with expanding role in cell biologyQ28294791
The MRC National Survey of Health and Development reaches age 70: maintaining participation at older ages in a birth cohort studyQ28584506
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's diseaseQ29614952
The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis.Q51769632
Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.Q51899594
APOE genotype and cognitive functioning in a large age-stratified population sample.Q51908317
Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.Q52018805
Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks.Q52019778
Apolipoprotein E polymorphism and Alzheimer's disease.Q53316388
Longitudinal change in working memory as a function of APOE genotype in midlife and old age.Q33719330
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effectQ34087105
Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programmeQ34116095
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyQ34332159
Clinical disorders in a post war British cohort reaching retirement: evidence from the First National Birth Cohort studyQ34427543
Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriersQ34922644
Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sampleQ35995579
Tau positron emission tomographic imaging in aging and early Alzheimer diseaseQ36535275
Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and DevelopmentQ36798784
APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive declineQ37360798
Prodromal Alzheimer's disease: successive emergence of the clinical symptomsQ38385065
Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's diseaseQ38426030
The role of extracerebral cholesterol homeostasis and ApoE e4 in cognitive declineQ39761756
APOE polymorphism affects episodic memory among non demented elderly subjects.Q44587391
APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.Q44889436
MUC7 haplotype analysis: results from a longitudinal birth cohort support protective effect of the MUC7*5 allele on respiratory functionQ45245465
APOE genotype and cognitive change in young, middle-aged, and older adults living in the communityQ46989840
Lifetime antecedents of cognitive reserveQ47819027
Tau PET in Alzheimer disease and mild cognitive impairment.Q48648902
Lack of effect of the apolipoprotein E ε4 genotype on cognition during healthy agingQ48659010
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P304page(s)18
P577publication date2018-01-10
P1433published inTranslational PsychiatryQ15716636
P1476titleApolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course
P478volume8

Reverse relations

cites work (P2860)
Q92527510APOE ε4 Modifies Effect of Residential Greenness on Cognitive Function among Older Adults: A Longitudinal Analysis in China
Q90424400APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
Q61805618Fornix white matter glia damage causes hippocampal gray matter damage during age-dependent limbic decline
Q63352822Identifying the lifetime cognitive and socioeconomic antecedents of cognitive state: seven decades of follow-up in a British birth cohort study.
Q92427769Impaired memory-guided attention in asymptomatic APOE4 carriers
Q91931109Longitudinal associations between diurnal cortisol variation and later-life cognitive impairment
Q92453487Phenome-wide screening for traits causally associated with the risk of coronary artery disease
Q91771798Polygenic risk scores for Alzheimer's disease, and academic achievement, cognitive and behavioural measures in children from the general population
Q60923086Selenium Status Is Not Associated with Cognitive Performance: A Cross-Sectional Study in 154 Older Australian Adults
Q92354324Short-term adverse effects of the apolipoprotein E ε4 allele over language function and executive function in healthy older adults
Q92060683Systemic inflammation and modifiable risk factors for cognitive impairment in older persons: Findings from a British birth cohort
Q64121665The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk

Search more.